Last info update: December 2022
Deepa rajagopalan email & phone, vice president, new products at Intercept pharmaceuticals

Deepa Rajagopalan — Contact Information

Vice President, New Products

Deepa Rajagopalan's Email, Phone & Whatsapp Number and other Contact Information

  • Emails Email r***com
    d***com
    d***edu
    d***com
    Open contact Available for registered users
  • Location Location New York, New York, United States
  • Education Education Honors in Biochemistry","Graduated with distinction"]
  • Skills Skills Strategy · Due Diligence · Business Strategy · Portfolio Management · Management · Private Equity · Financial Modeling · Venture Capital · Corporate Development · Emerging Markets · Business Transformation · Analysis · Market Entry · Mergers And Acquisitions · Hedge Funds · M&a Experience · Business Development · Biotechnology · Entrepreneurship · Marketing Strategy · Healthcare · Financial Analysis · Strategic Consulting · Acquisition Integration · Investments · Equity Research · Valuation · Investment Advisory · Market Analysis · Growth Strategies · Strategic Plan

Deepa Rajagopalanis a Vice President, New Products. Works at Intercept Pharmaceuticals(United States). Located in New York, New York, United States. Open Deepa Rajagopalan's email & phone: R***com. Skilled in Strategy · Due Diligence · Business Strategy · Portfolio Management · Management · Private Equity · Financial Modeling · Venture Capital · Corporate Development · Emerging Markets · Business Transformation · Analysis · Market Entry · Mergers And Acquisitions · Hedge Funds · M&a Experience · Business Development · Biotechnology · Entrepreneurship · Marketing Strategy · Healthcare · Financial Analysis · Strategic Consulting · Acquisition Integration · Investments · Equity Research · Valuation · Investment Advisory · Market Analysis · Growth Strategies · Strategic Plan.

Experience of Deepa Rajagopalan

Deepa rajagopalan's Company Details

Intercept Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering and developing small molecule drugs and therapeutics for the treatment of chronic fibrotic and metabolic diseases. It offers INT-747, a FXR modulating agent that tre Read more ats patients with chronic autoimmune liver diseases. The company's drug development programs also focus on modulating bile acid receptors, and amelioration of metabolic and hepatic functions in chronic liver diseases. Intercept Pharmaceuticals, Inc. was founded in 2002 and is based in New York, New York.

  • Company Emails [email protected]
  • Company Phone 646-747-1000
  • Company Website interceptpharma.com
  • Company Location new york, new york, united states
  • Industry pharmaceuticals
  • Company Size 501-1000
  • Found Year 2022
Click to load map
Colleagues
Similar employees

Frequently Asked Questions

Directories